Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10706929rdf:typepubmed:Citationlld:pubmed
pubmed-article:10706929lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:10706929lifeskim:mentionsumls-concept:C0027051lld:lifeskim
pubmed-article:10706929lifeskim:mentionsumls-concept:C0241888lld:lifeskim
pubmed-article:10706929lifeskim:mentionsumls-concept:C0015502lld:lifeskim
pubmed-article:10706929lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:10706929lifeskim:mentionsumls-concept:C1442161lld:lifeskim
pubmed-article:10706929lifeskim:mentionsumls-concept:C0033413lld:lifeskim
pubmed-article:10706929lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:10706929lifeskim:mentionsumls-concept:C0441587lld:lifeskim
pubmed-article:10706929pubmed:issue1lld:pubmed
pubmed-article:10706929pubmed:dateCreated2000-5-9lld:pubmed
pubmed-article:10706929pubmed:abstractTextRecently, an association has been found between factor VII polymorphisms and the risk of familial myocardial infarction. To obtain a thorough evaluation of the influence of factor VII gene on the risk of myocardial infarction, we extended our analysis to the role of a decanucleotide insertion/deletion functional polymorphism (-323 0/10-bp) in the promoter region of factor VII and to possible interactions with the HVR4 intron polymorphism. We performed a case-control study of 176 patients with myocardial infarction, over 45 years, who had a familial history of arterial thrombosis and 227 control subjects without a personal or family history of cardiovascular disease. The frequency of the rare allele of 10 bp was lower in cases (0.14 95% CI, 0.10-0.17) than in controls (0.19 95% CI, 0.16-0.23; chi(2)=4.7, p=0.03). Allowing for Hardy-Weinberg equilibrium in controls and testing for association under restricted maximisation, there was a significant difference in genotype frequency between cases and controls (p=0.02). Carriers of the 10-bp allele had an odds ratio for myocardial infarction of 0.65 (95% CI, 0.37-1.12), in multivariate logistic regression analysis. Combination analysis of -323 0/10-bp and HVR4 polymorphisms shows half reduction in the risk of myocardial infarction in comparison with the reference group for all the other groups, suggesting that there was no additivity between the effect of the 10-bp and the H7 alleles. Our findings suggest that the promoter polymorphism of factor VII gene may influence the risk of familial myocardial infarction.lld:pubmed
pubmed-article:10706929pubmed:languageenglld:pubmed
pubmed-article:10706929pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10706929pubmed:citationSubsetIMlld:pubmed
pubmed-article:10706929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10706929pubmed:statusMEDLINElld:pubmed
pubmed-article:10706929pubmed:monthAprlld:pubmed
pubmed-article:10706929pubmed:issn0049-3848lld:pubmed
pubmed-article:10706929pubmed:authorpubmed-author:DonatiM BMBlld:pubmed
pubmed-article:10706929pubmed:authorpubmed-author:AmoreCClld:pubmed
pubmed-article:10706929pubmed:authorpubmed-author:IacovielloLLlld:pubmed
pubmed-article:10706929pubmed:authorpubmed-author:FalangaAAlld:pubmed
pubmed-article:10706929pubmed:authorpubmed-author:D'OrazioAAlld:pubmed
pubmed-article:10706929pubmed:authorpubmed-author:Di...lld:pubmed
pubmed-article:10706929pubmed:issnTypePrintlld:pubmed
pubmed-article:10706929pubmed:day1lld:pubmed
pubmed-article:10706929pubmed:volume98lld:pubmed
pubmed-article:10706929pubmed:ownerNLMlld:pubmed
pubmed-article:10706929pubmed:authorsCompleteYlld:pubmed
pubmed-article:10706929pubmed:pagination9-17lld:pubmed
pubmed-article:10706929pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:10706929pubmed:meshHeadingpubmed-meshheading:10706929...lld:pubmed
pubmed-article:10706929pubmed:meshHeadingpubmed-meshheading:10706929...lld:pubmed
pubmed-article:10706929pubmed:meshHeadingpubmed-meshheading:10706929...lld:pubmed
pubmed-article:10706929pubmed:meshHeadingpubmed-meshheading:10706929...lld:pubmed
pubmed-article:10706929pubmed:meshHeadingpubmed-meshheading:10706929...lld:pubmed
pubmed-article:10706929pubmed:meshHeadingpubmed-meshheading:10706929...lld:pubmed
pubmed-article:10706929pubmed:meshHeadingpubmed-meshheading:10706929...lld:pubmed
pubmed-article:10706929pubmed:meshHeadingpubmed-meshheading:10706929...lld:pubmed
pubmed-article:10706929pubmed:meshHeadingpubmed-meshheading:10706929...lld:pubmed
pubmed-article:10706929pubmed:meshHeadingpubmed-meshheading:10706929...lld:pubmed
pubmed-article:10706929pubmed:meshHeadingpubmed-meshheading:10706929...lld:pubmed
pubmed-article:10706929pubmed:meshHeadingpubmed-meshheading:10706929...lld:pubmed
pubmed-article:10706929pubmed:meshHeadingpubmed-meshheading:10706929...lld:pubmed
pubmed-article:10706929pubmed:meshHeadingpubmed-meshheading:10706929...lld:pubmed
pubmed-article:10706929pubmed:year2000lld:pubmed
pubmed-article:10706929pubmed:articleTitleThe decanucleotide insertion/deletion polymorphism in the promoter region of the coagulation factor VII gene and the risk of familial myocardial infarction.lld:pubmed
pubmed-article:10706929pubmed:affiliationIstituto di Ricerche Farmacologiche Mario Negri, "Angela Valenti" Laboratory of Genetic and Environmental Risk Factors for Thrombotic Disease, Department of Vascular Medicine and Pharmacology, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy.lld:pubmed
pubmed-article:10706929pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10706929pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10706929lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10706929lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10706929lld:pubmed